Juno halts planned sale of Velcade generic in settlement with Millennium, US
Intellectual Property 2020-03-24 11:08 am | Melbourne
Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.
For information on rights and reprints, contact subscriptions@lawyerly.com.au